UAE-based healthtech, BioSapien, extended its pre-Series A funding round to $7 million, with new investors lik ..Read More

UAE-based healthtech, BioSapien, extended its pre-Series A funding round to $7 million, with new investors like Golden Gate Ventures joining the round. This marked the first deployment of Golden Gate's dedicated MENA Fund. The extension follows a $5.5 million pre-Series A round in December, led by Global Ventures and supported by Dara Holdings. The funds will support BioSapien’s development of its drug delivery platform, MediChip™.
Read Less

• Healthtech

UAE-based healthtech, BioSapien raised $5.5 million in a pre-Series A fundraise, led by Global Ventures with p ..Read More

UAE-based healthtech, BioSapien raised $5.5 million in a pre-Series A fundraise, led by Global Ventures with participation from Dara Holdings. The capital will be used to fund BioSapien’s clinical trials in the UAE, with patient enrollments in Abu Dhabi set to begin in Q2 2025. The funds will also support increased product development, manufacturing, and the onboarding of new talent.
Read Less

• Healthtech

Saudi Arabia-based healthtech Thakaa Med has secured Seed investment through the Falak Angels syndicate. Found ..Read More

Saudi Arabia-based healthtech Thakaa Med has secured Seed investment through the Falak Angels syndicate. Founded in 2022 by Alwaleed Albadr, Thakaa Med specializes in AI-driven healthcare solutions, focusing on predictive, preventive, and personalized technologies. The capital will accelerate the enhancement of its AI models and support the market launch of its flagship products, Dental IQ and Chest IQ.
Read Less

• Healthtech